A cohort of 33 people at risk for Huntington's disease (HD), applying for genetic testing, were tested with a battery of neuropsychological tests covering attentional, visuospatial, learning, memory, and planning functions. A psychiatric rating scale, SCL-90R, was also applied, mainly as a control, since cognitive dysfunction could be ascribed to functional disorders as well as neurodegenerative processes.
Huntington's disease (HD) is a neurodegenerative disorder with autosomal dominant inheritance and complete penetrance. The mean age of onset is between 35 and 44 years, leading to death after about 15 years. Clinical diagnosis is based on family history and onset of involuntary, choreiform movements. ' The HD gene was localised to the short arm of chromosome 4 by genetic linkage analyses of RFLPs2 making presymptomatic testing of at risk subjects possible by linkage analysis. Direct analysis of the gene became available when the mutation was identified as an unstable (CAG),. trinucleotide repeat in the 5' coding region of the HD gene. 34 The main purpose of the present paper is to report on neuropsychological characteristics of the first 40 persons who requested a presymptomatic test for HD in Denmark. In several studies neuropsychological dysfunction has been found after the onset of HD5-7 increasing in severity as HD progresses. 8 Identification of neuropsychological dysfunction in the premorbid mental state in persons at risk for HD can provide knowledge about the earliest effect of HD on cognition and thus about the relation between brain processes and behaviour. Marker analyses, and especially direct DNA analysis, have made this kind of investigation possible in a naturally blind set- ting.'-" The findings of such studies differ concerning the presence of neuropsychological dysfunction. However, one of the most recent studies found "evidence of presymptomatic cognitive decline in HD"."
Closely related to the neuropsychological studies is the issue ofpresymptomatic and early psychiatric symptoms.'3-" The main finding in this area is that depression is common, but that severe psychiatric morbidity is seldom present in these stages of HD.
In our study, a battery of neuropsychological tests covering basic as well as more complex cognitive functions related to different parts of the brain was used. A self-rating scale for psychiatric symptoms was added mainly as a control, as neuropsychological dysfunction could be ascribed to psychiatric illness as well as neurodegenerative processes.
Materials and methods
The first Danish persons at risk for HD attending for genetic testing were consecutively included in a cohort of 40 subjects. The recommendations for procedure of genetic testing programmes were followed."6 The study was between 0 and 1 (no problem and "a little bit") in carriers as well as non-carriers, indicating that intensity of self-reported psychiatric symptoms was far below the levels corresponding to a psychiatric case. In contrast to the SCL-90R, neuropsychological tests showed several significant differences between carriers and non-carriers (table  3) . Psychomotor speed, attention, and concentration were lowered in the more complex tests.
Different aspects of the verbal learning and memory processes were assessed by the categorial learning test (CVLT), the word-picture association and Pictogram, the story recall test (WMS), and CVLT. The difference in learning profiles for words, measured by CVLT (figure), riers were lower than norms, the carriers still had lower scores, indicating that stress related to the situation might influence the result, but that neuropsychological deficits explain the difference between carriers and non-carriers.
Given that cognitive impairment is present before onset of clinical manifestations of HD, the group of gene carriers should include subjects with different degrees of cognitive dysfunction dependent on time from onset. Age of onset varies, but a negative correlation between age and test score would suggest that cognitive decline in carriers explains the difference between groups. Although correlations between age and test scores were not statistically significant in any of the groups, negative correlations between all tests and age were closer to a statistically significant level in the carrier group than in the non-carrier group.
As the scores on SCL-90R were very low, differences could not be ascribed to depression or other types of functional psychopathology. We therefore conclude that cognitive impairment occurs before the onset of choreic movements and is unrelated to psychiatric symptoms in carriers of the HD gene. 
